Delving into the Latest Updates on ZHCX002 with Synapse

Overview

Basic Info

Drug Type

Chemical drugs

Synonyms

ZHCX002

Target-

Action-

Mechanism-

Therapeutic Areas

Infectious DiseasesRespiratory Diseases

Active Indication

PneumoniaCommunity Acquired Pneumonia

Inactive Indication-

Originator Organization

Anhui Jiuhua Huayuan Pharmaceutical Co., Ltd.

Active Organization

Anhui Jiuhua Huayuan Pharmaceutical Co., Ltd.Zhihe (Shandong) Pharmaceutical Co., Ltd.

Inactive Organization-

License Organization-

Drug Highest PhasePhase 1

First Approval Date-

Regulation-

Login to view timeline

主要目的：考察注射用阿奇霉素和阿奇霉素干混悬剂序贯给药在成人社区获得性肺炎患者体内的药代动力学特征。次要目的： 1.评价注射用阿奇霉素治疗成人社区获得性肺炎患者的安全性。 2. 评价注射用阿奇霉素治疗成人社区获得性肺炎患者的有效性。 3. 探索成人社区获得性肺炎患者PK/PD和PK/安全性的关系。

[Translation]

Primary objective: To investigate the pharmacokinetic characteristics of azithromycin for injection and azithromycin dry suspension in adults with community-acquired pneumonia after sequential administration. Secondary objectives: 1. To evaluate the safety of azithromycin for injection in the treatment of adult patients with community-acquired pneumonia. 2. To evaluate the effectiveness of azithromycin for injection in the treatment of adult patients with community-acquired pneumonia. 3. To explore the relationship between PK/PD and PK/safety in adult patients with community-acquired pneumonia.

Start Date-

Sponsor / Collaborator

Anhui Jiuhua Huayuan Pharmaceutical Co., Ltd.

[+1]

100 Clinical Results associated with ZHCX002

Login to view more data

100 Translational Medicine associated with ZHCX002

Login to view more data

100 Patents (Medical) associated with ZHCX002

Login to view more data

100 Deals associated with ZHCX002

Login to view more data

R&D Status

10 top R&D records.

Login

to view more data

Indication	Highest Phase	Country/Location	Organization	Date
Pneumonia	Phase 1	China	Zhihe (Shandong) Pharmaceutical Co., Ltd.	22 Jul 2025
Pneumonia	Phase 1	China	Anhui Jiuhua Huayuan Pharmaceutical Co., Ltd.	22 Jul 2025
Community Acquired Pneumonia	IND Approval	China	Anhui Jiuhua Huayuan Pharmaceutical Co., Ltd.	17 Jun 2025